当前位置: 首页 >> 检索结果
共有 5290 条符合本次的查询结果, 用时 2.1894074 秒

4761. Effective post-pandemic governance must focus on shared challenges.

作者: Anne Williamson.;Rebecca Forman.;Natasha Azzopardi-Muscat.;Robert Battista.;Francesca Colombo.;Amanda Glassman.;Josep Figueras Marimont.;Beata Javorcik.;Jim O'Neill.;Alistair McGuire.;Martin McKee.;Mario Monti.;Gus O'Donnell.;Clare Wenham.;Robert Yates.;Sally Davies.;Elias Mossialos.
来源: Lancet. 2022年399卷10340期1999-2001页

4762. Acute onset of fever, eosinophilia, rash, acute kidney injury, and a positive Monospot test in a patient on lamotrigine: DRESS syndrome.

作者: Mahmoud Abdelnabi.;Marawan Elmassry.;Jasmine Sekhon.;Juthipong Benjanuwattra.
来源: Lancet. 2022年399卷10338期1902页

4763. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.

作者: Alan Pollack.;Theodore G Karrison.;Alexander G Balogh.;Leonard G Gomella.;Daniel A Low.;Deborah W Bruner.;Jeffrey S Wefel.;Andre-Guy Martin.;Jeff M Michalski.;Steve J Angyalfi.;Himanshu Lukka.;Sergio L Faria.;George B Rodrigues.;Marie-Claude Beauchemin.;R Jeffrey Lee.;Samantha A Seaward.;Aaron M Allen.;Drew C Monitto.;Wendy Seiferheld.;Oliver Sartor.;Felix Feng.;Howard M Sandler.
来源: Lancet. 2022年399卷10338期1886-1901页
In men with a detectable prostate-specific antigen (PSA) level after prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in about 70% of patients being free of progression at 5 years. A three-group randomised trial was designed to determine whether incremental gains in patient outcomes can be achieved by adding either 4-6 months of short-term androgen deprivation therapy (ADT) to PBRT, or both short-term ADT and pelvic lymph node radiotherapy (PLNRT) to PBRT.

4764. Tofacitinib for juvenile idiopathic arthritis - Authors' reply.

作者: Nicolino Ruperto.;Hermine I Brunner.;Holly B Posner.;Irina Lazariciu.;Alberto Martini.;Daniel J Lovell.; .
来源: Lancet. 2022年399卷10338期1866页

4765. Tofacitinib for juvenile idiopathic arthritis.

作者: Grainne M Murray.;William D Renton.
来源: Lancet. 2022年399卷10338期1865-1866页

4766. Tobacco control: getting to the finish line.

作者: Robert Beaglehole.;Ruth Bonita.
来源: Lancet. 2022年399卷10338期1865页

4767. Yes, democracy is good for our health-but which democracy?

作者: Rafael Dall'Alba.;Marco André Germanò.;Cristianne Famer Rocha.
来源: Lancet. 2022年399卷10338期1864页

4768. Tobacco harm reduction matters.

作者: Darek Yach.
来源: Lancet. 2022年399卷10338期1864-1865页

4769. Capitalism, not racism.

作者: Roger L Albin.
来源: Lancet. 2022年399卷10338期1863页

4770. Decolonising global health: a Philippine perspective.

作者: Edward Christopher Dee.;Gideon Lasco.
来源: Lancet. 2022年399卷10338期1863页

4771. The truth about decolonising global health worth spreading.

作者: Juliet Iwelunmor.
来源: Lancet. 2022年399卷10338期1863-1864页

4772. Researcher trauma: when our stories collide.

作者: Ayesha Ahmad.
来源: Lancet. 2022年399卷10338期1860-1861页

4773. Migrant traumas heard.

作者: Delan Devakumar.;Rita Issa.
来源: Lancet. 2022年399卷10338期1859页

4774. Raj Panjabi: bringing a global outlook to the US pandemic response.

作者: Susan Jaffe.
来源: Lancet. 2022年399卷10338期1858页

4775. Zero COVID in China: what next?

作者: Shawn Yuan.
来源: Lancet. 2022年399卷10338期1856-1857页

4776. Calls to restart testing for parasitic disease at US CDC.

作者: Andrew Green.
来源: Lancet. 2022年399卷10338期1855页

4777. Health organizations fear effects of US abortion ruling.

作者: Susan Jaffe.
来源: Lancet. 2022年399卷10338期1854页

4778. Offline: Bill Gates and the fate of WHO.

作者: Richard Horton.
来源: Lancet. 2022年399卷10338期1853页

4779. Why Roe v. Wade must be defended.

作者: The Lancet.
来源: Lancet. 2022年399卷10338期1845页

4780. Prevention of conflict-related sexual violence in Ukraine and globally.

作者: Lindsay Stark.;Kim Thuy Seelinger.;Reine-Marcella Ibala.;Yana Tovpeko.;Denis Mukwege.
来源: Lancet. 2022年399卷10342期2173-2175页
共有 5290 条符合本次的查询结果, 用时 2.1894074 秒